TipRanks
Advertisement
Advertisement

AU:CYC Stock Latest News

Cyclopharm Flags Uncertainties Around First-Half 2026 Results
Company AnnouncementsCyclopharm Flags Uncertainties Around First-Half 2026 Results
1M ago
CYC
Cyclopharm Delivers Higher Revenue but Wider Half-Year Loss
PremiumCompany Announcements
Cyclopharm Delivers Higher Revenue but Wider Half-Year Loss
1M ago
CYC
Technegas Secures Preferred Status in Landmark U.S. Lung Imaging Guidelines
PremiumCompany Announcements
Technegas Secures Preferred Status in Landmark U.S. Lung Imaging Guidelines
2M ago
CYC
Cyclopharm Flags Uncertainties Around Financial Projections in ausbiz Briefing
PremiumCompany Announcements
Cyclopharm Flags Uncertainties Around Financial Projections in ausbiz Briefing
2M ago
CYC
Cyclopharm Adjusts Capital Structure as Conditional Share Rights Lapse
PremiumCompany Announcements
Cyclopharm Adjusts Capital Structure as Conditional Share Rights Lapse
3M ago
CYC
Cyclopharm Posts Record Half-Year Revenue but Defers U.S. Technegas Installation Target
PremiumCompany AnnouncementsCyclopharm Posts Record Half-Year Revenue but Defers U.S. Technegas Installation Target
3M ago
CYC
Cyclopharm Director Kevin Barrow Steps Down but Retains Indirect Shareholding
Premium
Company Announcements
Cyclopharm Director Kevin Barrow Steps Down but Retains Indirect Shareholding
5M ago
CYC
Cyclopharm Discloses Final Director Interest as Heaney Exits Board
Premium
Company Announcements
Cyclopharm Discloses Final Director Interest as Heaney Exits Board
5M ago
CYC
Cyclopharm shareholders back all resolutions at 2026 AGM
PremiumCompany Announcements
Cyclopharm shareholders back all resolutions at 2026 AGM
5M ago
CYC
Cyclopharm Highlights Uncertainty and Liability Limits in 2026 AGM Presentation
PremiumCompany Announcements
Cyclopharm Highlights Uncertainty and Liability Limits in 2026 AGM Presentation
5M ago
CYC
Cyclopharm Posts Record Revenue as U.S. Technegas Push Accelerates
PremiumCompany Announcements
Cyclopharm Posts Record Revenue as U.S. Technegas Push Accelerates
5M ago
CYC
Cyclopharm Touts Record Revenue as U.S. Technegas Rollout Accelerates
PremiumCompany Announcements
Cyclopharm Touts Record Revenue as U.S. Technegas Rollout Accelerates
5M ago
CYC
Cyclopharm Appoints New Director With No Current Security Holdings
PremiumCompany AnnouncementsCyclopharm Appoints New Director With No Current Security Holdings
5M ago
CYC
Cyclopharm completes A$14m institutional share placement
Premium
Company Announcements
Cyclopharm completes A$14m institutional share placement
5M ago
CYC
Cyclopharm seeks ASX quotation for over 5.2 million new shares
Premium
Company Announcements
Cyclopharm seeks ASX quotation for over 5.2 million new shares
5M ago
CYC
Cyclopharm names sole $5m investor in Tranche 2 placement
PremiumCompany Announcements
Cyclopharm names sole $5m investor in Tranche 2 placement
5M ago
CYC
Cyclopharm sets 2026 AGM to vote on governance and capital measures
PremiumCompany Announcements
Cyclopharm sets 2026 AGM to vote on governance and capital measures
6M ago
CYC
Cyclopharm Director John Wigglesworth Steps Down, Retains Shareholding
PremiumCompany Announcements
Cyclopharm Director John Wigglesworth Steps Down, Retains Shareholding
6M ago
CYC
Cyclopharm reshapes board as it accelerates Technegas push in U.S. market
PremiumCompany Announcements
Cyclopharm reshapes board as it accelerates Technegas push in U.S. market
6M ago
CYC
Cyclopharm lodges updated ASX corporate governance statement for 2025
PremiumCompany AnnouncementsCyclopharm lodges updated ASX corporate governance statement for 2025
6M ago
CYC
Cyclopharm Showcases Global Reach and 2025 Performance in Annual Report
Premium
Company Announcements
Cyclopharm Showcases Global Reach and 2025 Performance in Annual Report
6M ago
CYC
Cyclopharm Wins Multi-Site Technegas Deal with Northwestern Medicine
Premium
Company Announcements
Cyclopharm Wins Multi-Site Technegas Deal with Northwestern Medicine
6M ago
CYC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >